Group One Trading
BCAB icon

Group One Trading’s BioAtla BCAB Stock Holding History

Group One Trading’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8
Closed -$236 – 7587
2024
Q4 		$236 Sell
8
-16
-67% -$1.34K ﹤0.01% 7056
2024
Q3 		$2.11K Buy
24
+16
+200% +$1.34K ﹤0.01% 6132
2024
Q2 		$548 Buy
8
+6
+300% +$714 ﹤0.01% 6439
2024
Q1 		$344 Hold
2
– – ﹤0.01% 6772
2023
Q4 		$246 Hold
2
– – ﹤0.01% 7154
2023
Q3 		$170 Buy
+2
New +$255 ﹤0.01% 7439
2023
Q2 		– Sell
-124
Closed -$16.6K – 7639
2023
Q1 		$16.6K Buy
+124
New +$22.3K ﹤0.01% 5631
2022
Q4 		– Sell
-30
Closed -$12K – 7227
2022
Q3 		$12K Buy
+30
New +$9.82K ﹤0.01% 6369

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's BCAB Position: Q4 2025 in Review

Group One Trading sold out of BioAtla (BCAB) in Q4 2025, closing a stake of 23 shares — an estimated $795 sold.

Group One Trading first reported a position in BCAB in Q3 2021 and held it in 14 quarters. The position peaked at $157K in Q2 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q4 2025.

  • Group One Trading reported no remaining BioAtla position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 23 BioAtla shares in Q4 2025, an estimated $795.
  • Group One Trading first reported a position in BioAtla in Q3 2021 and held it in 14 quarters.
  • Group One Trading's BioAtla position peaked at $157K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.